- Home
- SGMO vs PAYS Comparison
SGMO vs PAYS Comparison
Compare SGMO & PAYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- PAYS
- Stock Information
- Founded
- SGMO 1995
- PAYS 2001
- Country
- SGMO United States
- PAYS United States
- Employees
- SGMO N/A
- PAYS N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- PAYS Business Services
- Sector
- SGMO Health Care
- PAYS Consumer Discretionary
- Exchange
- SGMO Nasdaq
- PAYS Nasdaq
- Market Cap
- SGMO 122.8M
- PAYS 125.2M
- IPO Year
- SGMO 2000
- PAYS 1998
- Fundamental
- Price
- SGMO $0.46
- PAYS $5.45
- Analyst Decision
- SGMO Buy
- PAYS Strong Buy
- Analyst Count
- SGMO 6
- PAYS 4
- Target Price
- SGMO $4.50
- PAYS $6.56
- AVG Volume (30 Days)
- SGMO 4.1M
- PAYS 503.5K
- Earning Date
- SGMO 08-05-2025
- PAYS 07-30-2025
- Dividend Yield
- SGMO N/A
- PAYS N/A
- EPS Growth
- SGMO N/A
- PAYS N/A
- EPS
- SGMO N/A
- PAYS 0.11
- Revenue
- SGMO $63,756,000.00
- PAYS $63,792,627.00
- Revenue This Year
- SGMO N/A
- PAYS $30.03
- Revenue Next Year
- SGMO N/A
- PAYS $20.14
- P/E Ratio
- SGMO N/A
- PAYS $49.74
- Revenue Growth
- SGMO 239.92
- PAYS 26.77
- 52 Week Low
- SGMO $0.30
- PAYS $1.80
- 52 Week High
- SGMO $3.18
- PAYS $5.59
- Technical
- Relative Strength Index (RSI)
- SGMO 38.27
- PAYS 77.72
- Support Level
- SGMO $0.49
- PAYS $4.72
- Resistance Level
- SGMO $0.51
- PAYS $5.10
- Average True Range (ATR)
- SGMO 0.04
- PAYS 0.27
- MACD
- SGMO 0.01
- PAYS 0.00
- Stochastic Oscillator
- SGMO 6.25
- PAYS 91.18
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About PAYS Paysign Inc.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.